HeartStitch(R) Brings New Technology to Astana to Treat Structural Heart Disease
Revolutionary, Minimally Invasive Intervention Allows Physicians to Successfully Close PFOs in Kazakh Patients
(firmenpresse) - LOS ANGELES, CA -- (Marketwired) -- 09/11/15 -- Specialists of the in Astana, Kazakhstan together with , and with the guidance of , performed a new, minimally invasive procedure to close the of the heart using the device for cardiovascular suturing. This was successfully performed without invasive open-heart surgery. is a hole in the heart that ordinarily will close at birth, but more than 27% of the population this tunnel remains open.
Three patients, ranging from 13 - 42 years of age with congenital heart disease underwent this minimally invasive intervention under visual fluoroscopic control. These cases demonstrated several of the fundamental differences between the new type of procedure using the which uses only sutures to close the heart defect, versus large medical device implants that are known for potentially life threatening complications in some patients. The percutaneous PFO tunnel is sewn "closed" using the method with a routine cardiac catheterization procedure rather than implanting a large metal disc in the heart or the much more invasive open-heart surgery procedure.
Stroke, Debilitating severe migraines often accompanied by visual aura and chronic fatigue have long been associated with PFO, which led to the National Stroke Center to work with Dr. Mullen and HeartStitch to train cardiologists at the NRCSC identifying those patients and the technique to test for the PFO. This is the first device of its kind used in Astana starting with the first patient treated last year during the Master Class which established a new awareness of the relationship between PFO stroke and other structural heart problems.
leading expert in structural heart interventions at NCRC present to perform the cases on the three patients in Astana. Dr. Kadirova said, "We are gratified that our colleagues from abroad have brought this technology to Kazakhstan. We now have the ability to perform these important, minimally invasive procedures and thank Dr. Mullen and Professor Nobles, who invented this innovative solution for cardiologists. We can now treat the Kazakhstani people using this practice."
commented, "Working with such talented physicians makes the training of our NobleStitch technology more effective. Working with cardiology centers like NRCSC allows us to provide safe alternatives for PFO closure. It is gratifying for me to bring our latest technological breakthrough to Kazakhstan. Clinical successes as we have had here in Astana are the driving force for our continued growth worldwide."
®
was founded in Fountain Valley, California by Prof. Anthony Nobles, a successful entrepreneur who has an established track record of development, commercialization and M&A transactions in the medical device space. is currently focused on the development and commercialization of devices in the structural heart space.
With a focus in Structural Heart treatments, was founded to bring its established suture technology to the treatment of several structural heart applications including "Trans-Apical Access and Closure," "Mitral Valve Remodeling" and "Mitral Valve Annulplasty."
The NobleStitch is approved for PFO Closure and Cardiovascular suturing in the European Union. The NobleStitch EL is FDA cleared for vascular suturing in the United States. The HeartStitch TA and HeartStitch MR are 510K cleared for vascular suturing in the United States.
NobleStitch™ EL is distributed worldwide by HeartStitch®, Inc.
HeartStitch® is a registered trademark of HeartStitch, Inc.
The NobleStitch and HeartStitch products have several US and International patents and filings.
Professor Anthony (Tony) Nobles is considered one of the great minds in the medical device field. He is world-renown inventor, professor, lecturer, author, mentor, entrepreneur, CEO of various companies and biomedical engineer. On the personal side, Tony is also a Formula One racecar driver, Warbird pilot, philanthropist and most importantly, a devoted husband and father of six.
Image Available:
Image Available:
Image Available:
Image Available:
Image Available:
Bobbi Marcus PR & Events, Inc.
P. 310.889.9200
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.09.2015 - 05:00 Uhr
Sprache: Deutsch
News-ID 1384811
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LOS ANGELES, CA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 179 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"HeartStitch(R) Brings New Technology to Astana to Treat Structural Heart Disease
"
steht unter der journalistisch-redaktionellen Verantwortung von
HeartStitch, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
